Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Directorate Change

5 Aug 2005 11:18

Quadnetics Group PLC05 August 2005 Quadnetics Group plc 5 August 2005 Board Changes Quadnetics Group plc, a leader in the design, integration and control ofadvanced CCTV and networked video surveillance systems, announces that it hasappointed two additional executive directors to its Board: David Orme becomesGroup Operations Director, and Glenn Robinson becomes Group Technical & BusinessDevelopment Director. Prior to joining the Company Mr David Orme was Chief Operating Officer of BellGroup plc, a successful quoted electronic security systems supplier. Mr Ormehas wide experience and an excellent track record of achievement in the securitysystems industry, and the Board is delighted he has agreed to join Quadnetics. Glenn Robinson joined Quadnetics in 1997 and has most recently been responsiblefor successful development and delivery of the Company's large-scale digitalsecurity systems in the UK and Canada. In his new role, his primary focus willbe to help achieve rapid growth of Synectics' digital security systems businessin the United States, working with the local management of recently acquiredSynectics, Inc. In addition, the Company's Chairman, Peter Rae, has requested to stand down asChairman, due to the increasing pressure of other business commitments. Mr Raehas agreed to remain as senior independent non-executive director for a periodof up to a year. David Coghlan, Deputy Chairman, has been appointed Chairman,effective from 4th August. Following the announcement dated 22 April 2005, and the end of the Company'sfinancial year, the Board's expectations remain that consolidated profit beforetax and goodwill amortisation for the year ended 31 May 2005 will be not lessthan Β£2.6 million. As previously predicted, sales achieved by the Company'sdigital security systems subsidiary, Synectics, were more than double those ofthe previous year, at margins ahead of budgeted expectations. Russ Singleton, Chief Executive, commented: "I am delighted to welcome David Orme and Glenn Robinson to the Board. Thisstrengthening of the Group-level executive team will significantly expand theCompany's capacity to achieve the growth objectives we have set ourselves. Inparticular, it will increase our scope for capitalising on the marketopportunities we are now seeing for major digital security systems in the UK andNorth America." David Michael Orme, aged 41, is or has been a director of the followingcompanies and organisations during the past five years Current Directorships Directorships held in the past five yearsNil Bell Group plc Bell Security Limited Glenn Robinson, aged 39, is or has been a director of the following companiesand organisations during the past five years: Current Directorships Directorships held in the past five yearsSynectic Systems Limited A1 Presentations Limited Quadrant Rentals Limited Quadrant Research & Development Limited Quadrant Video Systems plc SJC120 Limited Stanmore Systems Limited There is no other information that is required to be disclosed under Schedule 2paragraph (g) of the AIM Rules. Enquiries: Peter Curtain / Ariane Comstive Tel: +44 020 7398 7700Abchurch Communicationsariane.comstive@abchurch-group.com Neil Baldwin Tel: +44 0113 241 0130Brewin Dolphin Securitiesneil.baldwin@brewin.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Mar 20114:35 pmRNSAvailability of Report & Accounts
8th Mar 20117:00 amRNSRe: 2009 Group Executive Shared Ownership Plan
4th Mar 20117:00 amRNSPreliminary Results
1st Feb 201111:06 amRNSNotification of Results
7th Jan 20114:02 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSAcquisition
21st Dec 201010:45 amRNSHolding(s) in Company
21st Dec 20107:00 amRNSHolding(s) in Company
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20107:00 amRNSPost Year End Trading Update
27th Jul 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSInterim Results
21st Jan 201010:36 amRNSContract Win
15th Jan 20102:59 pmRNSREPLACEMENT: Notice of Results
15th Jan 201010:35 amRNSNotice of Results
11th Nov 200910:59 amRNSResult of AGM
5th Nov 20097:00 amRNSTrading Update
9th Sep 20097:00 amRNSPreliminary Results
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change
5th Sep 20077:01 amRNSPreliminary Results
22nd Aug 20073:17 pmRNSHolding(s) in Company
22nd Aug 200711:19 amRNSAIM RULE 26
15th Jun 20071:26 pmRNSGrant of Options
13th Jun 20077:01 amRNSPreliminary Results
24th May 20074:24 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.